Pharma Companies Pharmacy Regulation Sales 
pharmaphorum
JANUARY 8, 2021
The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications.
pharmaphorum
FEBRUARY 25, 2022
Pharma companies are now household names, having been thrust into the public’s consciousness after dominating the headlines through the pandemic. Therefore, harnessing this new collaborative approach could be the best way to strengthen trust in pharma. The past two years have shone a spotlight on the UK life sciences industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 26, 2021
Life sciences companies need to rethink their customer engagement paradigms in light of changing customer preferences. Pharma companies will need to continually rethink what works and not be afraid to experiment with solutions they’ve never tried before. As such, reps will need to be reskilled.
pharmaphorum
OCTOBER 3, 2022
Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses. About the author.
Drug Discovery World
MARCH 29, 2023
The commission is looking to put more pressure on pharma companies to report such shortages, and to offer a drug’s marketing authorisation to another company before withdrawing it from the market. She also does not believe that the problems with Europe’s medicines can be solved with regulation.
pharmaphorum
JUNE 10, 2021
If pharmaceutical companies’ steady price increases are wholly due to limitless greed or thirst for revenue growth, this certainly is not proven by the actual, factual financial results for these same companies. These payers are best defined as entities that pay for or reimburse pharmacies for drugs dispensed to covered patients.
XTalks
MARCH 22, 2023
While not a record-breaking deal at $17 billion, the buyout strengthened Pfizer’s injectables business unit with the company reporting an 11 percent increase in revenue the following year. More potential patients equal more prescriptions which equals higher sales and bigger profits.
Expert insights. Personalized for you.
99 
Let's personalize your content